BVNKF:OTC-Bavarian Nordic A/S (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 36.4268

Change

-0.47 (-1.28)%

Market Cap

N/A

Volume

349.00

Analyst Target

USD 62.19
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
UCBJY UCB SA ADR

-3.59 (-3.92%)

USD 34.50B
UCBJF UCB SA

N/A

USD 34.08B
ARGNF argenx SE

N/A

USD 32.00B
GNMSF Genmab A/S

-1.32 (-0.51%)

USD 17.00B
ZLDPF Zealand Pharma A/S

N/A

USD 9.86B
IVBIY IVBIY

N/A

USD 8.92B
SBHMY Sino Biopharmaceutical Ltd ADR

N/A

USD 7.29B
SBMFF Sino Biopharmaceutical Limited

N/A

USD 7.27B
AKESF Akeso, Inc.

-0.10 (-1.06%)

USD 7.07B
WXIBF WuXi Biologics

N/A

USD 6.08B

ETFs Containing BVNKF

EL4D:XETRA Deka STOXX Europe Strong .. 6.87 % 0.00 %

+0.29 (+0.00%)

USD 0.03B
EL4E:XETRA Deka STOXX Europe Strong .. 3.83 % 0.00 %

+0.07 (+0.00%)

USD 0.04B
ETLI:XETRA L&G Pharma Breakthrough U.. 2.74 % 0.00 %

+0.04 (+0.00%)

USD 0.02B
BIOT:SW L&G Pharma Breakthrough U.. 2.69 % 0.00 %

N/A

N/A
VIDI Vident International Equi.. 0.63 % 0.63 %

+0.02 (+0.00%)

USD 0.34B
GWX SPDR® S&P International .. 0.00 % 0.40 %

-0.10 (0.00%)

N/A
ETLI:F Legal & General UCITS ETF.. 0.00 % 0.00 %

-0.03 (0.00%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 38.87% 76% C+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.87% 76% C+ 82% B
Trailing 12 Months  
Capital Gain 70.94% 87% B+ 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 70.94% 86% B+ 88% B+
Trailing 5 Years  
Capital Gain 44.26% 82% B 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.26% 82% B 75% C
Average Annual (5 Year Horizon)  
Capital Gain 8.34% 54% F 52% F
Dividend Return 8.34% 54% F 48% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 50.48% 65% D 50% F
Risk Adjusted Return 16.52% 69% C- 51% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:

There is nothing we particularly dislike